Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 24, 2018 (8 years ago)

Chlorhexidine 0.12% liquid

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Chlorhexidine 0.12% liquid, 473 MILLITERS. Rx Only. Mnfct for: XTTRUM Laboratories, Chicago, IL 60609. Mnfct by: pharmaceutical Assoiates, Inc., Greenville, SC 29605. Distrib by: PreScript Pharm. INC., Pleasanton, CA 94588. NDC: 00116-2001-16, Bar Code 1385-38-482

Affected NDC 0116-2001-16

Compare with the code on your package — it is the most precise check available.

Drug: Chlorhexidine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Chlorhexidine Gluconate
NDC 00116-2001
1.2 mg/mL Rinse
Oral
Xttrium Laboratories, Inc. Rx
Recalling firm
Prescript Pharmaceuticals, Inc.
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0807-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Chlorhexidine recalls

See all
Class II · Moderate risk

BD ChloraPrep Clear

Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-31 D-0690-2026
Class II · Moderate risk

BD ChloraPrep CLear

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-34 D-0652-2026
Class II · Moderate risk

BD ChloraPrep CLear

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-31 D-0651-2026
Class II · Moderate risk

BD ChloraPrep Scrub Teal

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-39 D-0650-2026

Other recalls by Prescript Pharmaceuticals, Inc.

All 2018 recalls
Class II · Moderate risk

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Terminated Labeling / mix-up Prescript Pharmaceuticals, Inc. D-0809-2018
Class II · Moderate risk

Clindamycin 300 mg capsules

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Terminated Labeling / mix-up Prescript Pharmaceuticals, Inc. D-0808-2018
Class II · Moderate risk

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Terminated Labeling / mix-up Prescript Pharmaceuticals, Inc. D-0806-2018
Class II · Moderate risk

Clindamycin 150 mg capsules

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Terminated Labeling / mix-up Prescript Pharmaceuticals, Inc. D-0805-2018